115 related articles for article (PubMed ID: 14757492)
1. Long-term stabilisation potential of poly(vinylpyrrolidone) for amorphous lactose in spray-dried composites.
Berggren J; Alderborn G
Eur J Pharm Sci; 2004 Feb; 21(2-3):209-15. PubMed ID: 14757492
[TBL] [Abstract][Full Text] [Related]
2. Effect of polymer content and molecular weight on the morphology and heat- and moisture-induced transformations of spray-dried composite particles of amorphous lactose and poly(vinylpyrrolidone).
Berggren J; Alderborn G
Pharm Res; 2003 Jul; 20(7):1039-46. PubMed ID: 12880290
[TBL] [Abstract][Full Text] [Related]
3. Phase behavior of poly(vinylpyrrolidone) containing amorphous solid dispersions in the presence of moisture.
Rumondor AC; Marsac PJ; Stanford LA; Taylor LS
Mol Pharm; 2009; 6(5):1492-505. PubMed ID: 19634917
[TBL] [Abstract][Full Text] [Related]
4. Water-solid interactions. III. Effect of glass transition temperature, Tg, and processing on tensile strength of compacts of lactose and lactose/polyvinyl pyrrolidone.
Stubberud L; Arwidsson HG; Hjortsberg V; Graffner C
Pharm Dev Technol; 1996 Jul; 1(2):195-204. PubMed ID: 9552346
[TBL] [Abstract][Full Text] [Related]
5. Ability of different polymers to inhibit the crystallization of amorphous felodipine in the presence of moisture.
Konno H; Taylor LS
Pharm Res; 2008 Apr; 25(4):969-78. PubMed ID: 17520180
[TBL] [Abstract][Full Text] [Related]
6. Moisture sorption behavior of selected bulking agents used in lyophilized products.
Fakes MG; Dali MV; Haby TA; Morris KR; Varia SA; Serajuddin AT
PDA J Pharm Sci Technol; 2000; 54(2):144-9. PubMed ID: 10822985
[TBL] [Abstract][Full Text] [Related]
7. Physical stability of the amorphous state of loperamide and two fragment molecules in solid dispersions with the polymers PVP-K30 and PVP-VA64.
Weuts I; Kempen D; Decorte A; Verreck G; Peeters J; Brewster M; Van den Mooter G
Eur J Pharm Sci; 2005 Jun; 25(2-3):313-20. PubMed ID: 15911228
[TBL] [Abstract][Full Text] [Related]
8. Effect of moisture sorption on tabletting characteristics of spray dried (15% amorphous) lactose.
Sebhatu T; Elamin AA; Ahlneck C
Pharm Res; 1994 Sep; 11(9):1233-8. PubMed ID: 7816749
[TBL] [Abstract][Full Text] [Related]
9. Intrinsic adhesion properties of poly(vinyl pyrrolidone) to pharmaceutical materials: humidity effect.
Lee J
Macromol Biosci; 2005 Nov; 5(11):1085-93. PubMed ID: 16245267
[TBL] [Abstract][Full Text] [Related]
10. The effect of low concentrations of molecularly dispersed poly(vinylpyrrolidone) on indomethacin crystallization from the amorphous state.
Crowley KJ; Zografi G
Pharm Res; 2003 Sep; 20(9):1417-22. PubMed ID: 14567636
[TBL] [Abstract][Full Text] [Related]
11. Characterization of the molecular distribution of drugs in glassy solid dispersions at the nano-meter scale, using differential scanning calorimetry and gravimetric water vapour sorption techniques.
van Drooge DJ; Hinrichs WL; Visser MR; Frijlink HW
Int J Pharm; 2006 Mar; 310(1-2):220-9. PubMed ID: 16427226
[TBL] [Abstract][Full Text] [Related]
12. Recrystallization of nifedipine and felodipine from amorphous molecular level solid dispersions containing poly(vinylpyrrolidone) and sorbed water.
Marsac PJ; Konno H; Rumondor AC; Taylor LS
Pharm Res; 2008 Mar; 25(3):647-56. PubMed ID: 17846870
[TBL] [Abstract][Full Text] [Related]
13. Effect of temperature and moisture on the miscibility of amorphous dispersions of felodipine and poly(vinyl pyrrolidone).
Marsac PJ; Rumondor AC; Nivens DE; Kestur US; Stanciu L; Taylor LS
J Pharm Sci; 2010 Jan; 99(1):169-85. PubMed ID: 19492305
[TBL] [Abstract][Full Text] [Related]
14. The influence of PVP incorporation on moisture-induced surface crystallization of amorphous spray-dried lactose particles.
Mahlin D; Berggren J; Gelius U; Engström S; Alderborn G
Int J Pharm; 2006 Sep; 321(1-2):78-85. PubMed ID: 16822629
[TBL] [Abstract][Full Text] [Related]
15. Water vapor absorption into amorphous hydrophobic drug/poly(vinylpyrrolidone) dispersions.
Crowley KJ; Zografi G
J Pharm Sci; 2002 Oct; 91(10):2150-65. PubMed ID: 12226842
[TBL] [Abstract][Full Text] [Related]
16. Differences in the interaction between aryl propionic acid derivatives and poly(vinylpyrrolidone) K30: A multi-methodological approach.
Gashi Z; Censi R; Malaj L; Gobetto R; Mozzicafreddo M; Angeletti M; Masic A; Di Martino P
J Pharm Sci; 2009 Nov; 98(11):4216-28. PubMed ID: 19645003
[TBL] [Abstract][Full Text] [Related]
17. Crystallization inhibition in solid dispersions of MK-0591 and poly(vinylpyrrolidone) polymers.
Khougaz K; Clas SD
J Pharm Sci; 2000 Oct; 89(10):1325-34. PubMed ID: 10980507
[TBL] [Abstract][Full Text] [Related]
18. Physicochemical stability of crystalline sugars and their spray-dried forms: dependence upon relative humidity and suitability for use in powder inhalers.
Naini V; Byron PR; Phillips EM
Drug Dev Ind Pharm; 1998 Oct; 24(10):895-909. PubMed ID: 9876544
[TBL] [Abstract][Full Text] [Related]
19. Co-relationship of physical stability of amorphous dispersions with enthalpy relaxation.
Bansal SS; Kaushal AM; Bansal AK
Pharmazie; 2008 Nov; 63(11):812-4. PubMed ID: 19069241
[TBL] [Abstract][Full Text] [Related]
20. Molecular mobility-based estimation of the crystallization rates of amorphous nifedipine and phenobarbital in poly(vinylpyrrolidone) solid dispersions.
Aso Y; Yoshioka S; Kojima S
J Pharm Sci; 2004 Feb; 93(2):384-91. PubMed ID: 14705195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
